Since Ptger4−/− mice develop severe dextran sodium sulphate (DSS)-induced colitis while treatment with EP4-selective agonists has protective effects against colitis through enhancement of epithelium survival and regeneration, PTGER4 represents an attractive IBD candidate gene [22]–[24]. This evidence concerns the gene PTGER4 and inflammatory bowel disease.